Lung Cancer Research Foundation Grant Program

Deadline: 04/30/2022

LCRF Pilot Grant Program

Lung cancer continues to be the number one cause of cancer deaths worldwide, accounting for an estimated
130,180 deaths annually in the United States alone. Despite being the most common cancer killer of both men
and women, lung cancer research remains critically underfunded. To help close this gap and improve outcomes,
the goal of the LCRF pilot grant program is to fund innovative projects across the full spectrum of basic,
translational, clinical, epidemiological, health services, early detection, disparities, and social determinants of
health research. 2022 LCRF pilot grants will provide $150,000 over a period of two years for projects including
but not limited to the following topics:
 Lung cancer biology
 Prevention and screening for early detection
 Identification of new biomarkers
 Development of more effective and less toxic therapies including but not limited to targeted and
immune-therapies
 Genetic and gene-environment interactions
 Interactions and contributions of multiple factors (e.g. smoking, genetics, environment, societal
factors) to disparities in lung cancer outcomes
 Mechanisms of sensitivity and resistance to lung cancer therapies
 Bioengineering approaches to understanding and/or treating lung cancer (i.e., theranostics,
biomaterials, nanotechnology, controlled-drug release, and gene-therapy)
 Supportive measures for people with lung cancer and their families

Letter of Intent Due April 30, 2022

Duration

2 years

Funding

Upper $150,000USD

Awards made through this funding mechanism will provide investigators up to $150,000 in funding over a period of two years.

Eligibility

Investigators must be affiliated with a non-profit academic or research institution and must be post-doctoral researchers, clinical fellows, or early-career and mid-career investigators with less than ten years’ experience since their initial faculty appointment.
Applicants from US-based and international institutions are eligible to apply and may hold any
residency/citizenship status. Applicants are prohibited from applying if they have received funding from the LCRF within the last 4 years. Senior investigators with more than ten years’ experience since faculty appointment are generally not eligible for funding and are encouraged to mentor a junior team member through the application process. However, exceptions will be made for investigators with more than ten years’ experience in other disease areas or topics.

Website

Contact

LCRF office
[email protected]